Correlation Between Madrigal Pharmaceuticals and Rigel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Rigel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Rigel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Rigel Pharmaceuticals, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Rigel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Rigel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Rigel Pharmaceuticals.
Diversification Opportunities for Madrigal Pharmaceuticals and Rigel Pharmaceuticals
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Madrigal and Rigel is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Rigel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rigel Pharmaceuticals and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Rigel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rigel Pharmaceuticals has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Rigel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and Rigel Pharmaceuticals
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 2.98 times less return on investment than Rigel Pharmaceuticals. But when comparing it to its historical volatility, Madrigal Pharmaceuticals is 1.69 times less risky than Rigel Pharmaceuticals. It trades about 0.21 of its potential returns per unit of risk. Rigel Pharmaceuticals is currently generating about 0.37 of returns per unit of risk over similar time horizon. If you would invest 1,363 in Rigel Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of 1,398 from holding Rigel Pharmaceuticals or generate 102.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. Rigel Pharmaceuticals
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| Rigel Pharmaceuticals |
Madrigal Pharmaceuticals and Rigel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and Rigel Pharmaceuticals
The main advantage of trading using opposite Madrigal Pharmaceuticals and Rigel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Rigel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rigel Pharmaceuticals will offset losses from the drop in Rigel Pharmaceuticals' long position.| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Pieris Pharmaceuticals | Rigel Pharmaceuticals vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |